These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22026398)

  • 21. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
    Staatz CE; Tett SE
    Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.
    Madian AG; Panigrahi A; Perera MA; Pinto N
    BMC Pharmacol Toxicol; 2014 Dec; 15():69. PubMed ID: 25472557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of generic cyclosporine arpimune in Filipino low-risk primary kidney transplant recipients.
    Pamugas GE; Danguilan RA; Lamban AB; Mangati VB; Ona ET
    Transplant Proc; 2012 Jan; 44(1):101-8. PubMed ID: 22310590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generic immunosuppressant use in solid organ transplantation.
    Alloway RR
    Transplant Proc; 1999 May; 31(3A Suppl):2S-5S. PubMed ID: 10330948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition from brand to generic tacrolimus is associated with a decrease in trough blood concentration in pediatric heart transplant recipients.
    Duong SQ; Lal AK; Joshi R; Feingold B; Venkataramanan R
    Pediatr Transplant; 2015 Dec; 19(8):911-7. PubMed ID: 26497983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines.
    Yu Y; Teerenstra S; Neef C; Burger D; Maliepaard M
    Eur J Clin Pharmacol; 2015 Aug; 71(8):979-90. PubMed ID: 26062932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological surrogates of allograft outcome.
    Mahalati K; Kahan BD
    Ann Transplant; 2000; 5(2):14-23. PubMed ID: 11217202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.
    Videla C; Godoy C
    Transplant Proc; 2007 Apr; 39(3):602-5. PubMed ID: 17445555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generic cyclosporine formulations: more open questions than answers.
    Cattaneo D; Perico N; Remuzzi G
    Transpl Int; 2005 Apr; 18(4):371-8. PubMed ID: 15773953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic Drugs - Decreasing Costs and Room for Increased Number of Kidney Transplantations.
    Spasovski G
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):133-8. PubMed ID: 27442379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus.
    Riva N; Cáceres Guido P; Licciardone N; Imventarza O; Monteverde M; Staciuk R; Charroqui A; Schaiquevich P
    Farm Hosp; 2017 Mar; 41(2):150-168. PubMed ID: 28236795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity.
    Tönshoff B; Höcker B
    Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter experience with generic tacrolimus conversion.
    McDevitt-Potter LM; Sadaka B; Tichy EM; Rogers CC; Gabardi S
    Transplantation; 2011 Sep; 92(6):653-7. PubMed ID: 21788920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioequivalence testing of immunosuppressants: concepts and misconceptions.
    Christians U; Klawitter J; Clavijo CF
    Kidney Int Suppl; 2010 Mar; (115):S1-7. PubMed ID: 20150904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improved immunosuppression leads to better kidney transplantations].
    Ekberg H
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1739-42. PubMed ID: 23097879
    [No Abstract]   [Full Text] [Related]  

  • 36. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Clinical and Safety Outcomes Following Uncontrolled Tacrolimus Conversion in Adult Transplant Recipients.
    Lichvar A; Tremblay S; Naik D; Lipscomb J; King E; Vinks AA; Christians U; Alloway RR
    Pharmacotherapy; 2019 May; 39(5):564-575. PubMed ID: 30892704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The adoption of generic immunosuppressant medications in kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare part D.
    Liu Q; Smith AR; Park JM; Oguntimein M; Dutcher S; Bello G; Helmuth M; Turenne M; Balkrishnan R; Fava M; Beil CA; Saulles A; Goel S; Sharma P; Leichtman A; Zee J
    Am J Transplant; 2018 Jul; 18(7):1764-1773. PubMed ID: 29603899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability of a generic of the immunosuppressive agent mycophenolate mofetil in pediatric patients.
    González-Ramírez R; González-Bañuelos J; Villa Mde L; Jiménez B; García-Roca P; Cruz-Antonio L; Castañeda-Hernández G; Medeiros M
    Pediatr Transplant; 2014 Sep; 18(6):568-74. PubMed ID: 24978101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.